Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
System and method for solving connection violations
Flow cytometer method and apparatus
Method and device for monitoring and analyzing signals
Method and apparatus for monitoring for a radio link failure
Organic metal complex and its use in organic electroluminescent device
Apparatus for merging spatial audio streams
Method and system for security authentication of radio frequency identification
  Randomly Featured Patents
Molten metal impeller
Leak monitor for secondary containment of liquid stored in underground storage tanks
Electric trace tube bundle with internal branch circuit
Procedure for producing hollow bodies of thermoplastic material
Tape player
African violet plant named Meg
Generic and dynamic mapping of abstract syntax notation (ASN1) to and from interface definition language for network management
Use of valerian plant and/or root as a scent-attractant for stimulating canines and felines
Pipe jointing unit
Apparatus for producing fog